[Myeloperoxidase-induced Biodegradation of Single-walled Carbon Nanotubes is Mediated by Hypochlorite]
Overview
Molecular Biology
Affiliations
Broad prospects for the use of single-walled carbon nanotubes (SWNTs) in medicine and biotechnology raise the concerns about both their toxicity, and the mechanisms of biodegradation and excretion from the body. SWNTs biodegradation as a result of catalytic activity of myeloperoxidase (MPO) was shown in the isolated MPO system as well as in the suspension of neutrophils [Kagan V.E., et al., 2010]. In the present study we analyzed the ability of different MPO-produced oxidants to participate in the modification and degradation of SWNTs. The comparison of the ability of various peroxidases to degrade SWNTs in vitro revealed that myeloperoxidase, due to its ability to produce hypochlorite, and lactoperoxidase, due to its ability to produce hypobromite, are extremely efficient in the degradation of carbon nanotubes. The biodegradation of SWNTs in the model system can also be caused by free radicals generated as a result of heme degradation and, to a lesser extent, by active oxoferryl intermediates of peroxidases. Our experiments showed that in the presence of blood plasma, peroxidase intermediates or free radical products of heme degradation were unable to initiate biodegradation of carbon nanotubes, only the generation of hypochlorite by MPO can cause the biodegradation of carbon nanotubes in vivo. Titration of SWNTs suspension containing plasma with hypochlorite at high concentrations resulted in the decrease in the optical absorbance of the suspension indicating the degradation of nanotubes. Our results clearly indicate that hypochlorite can serve as a main oxidizing agent which is able to modify and degrade nanotubes in the sites of inflammation and in the phagosomes.
Application of Nanomaterials in the Production of Biomolecules in Microalgae: A Review.
Yuan X, Gao X, Liu C, Liang W, Xue H, Li Z Mar Drugs. 2023; 21(11).
PMID: 37999418 PMC: 10672109. DOI: 10.3390/md21110594.
Asefi S, Moghimi H Sci Rep. 2023; 13(1):16139.
PMID: 37752200 PMC: 10522686. DOI: 10.1038/s41598-023-43517-9.
Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development.
de Carvalho Lima E, Diaz R, Justo J, Piqueira J Int J Nanomedicine. 2021; 16:5411-5435.
PMID: 34408416 PMC: 8367085. DOI: 10.2147/IJN.S314308.
Toxicity of Zero- and One-Dimensional Carbon Nanomaterials.
Raja I, Song S, Kang M, Lee Y, Kim B, Hong S Nanomaterials (Basel). 2019; 9(9).
PMID: 31466309 PMC: 6780407. DOI: 10.3390/nano9091214.
Yang M, Zhang M, Nakajima H, Yudasaka M, Iijima S, Okazaki T Int J Nanomedicine. 2019; 14:2797-2807.
PMID: 31118611 PMC: 6501421. DOI: 10.2147/IJN.S199187.